These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Do statins afford neuroprotection in patients with cerebral ischaemia and stroke? Vaughan CJ; Delanty N; Basson CT CNS Drugs; 2001; 15(8):589-96. PubMed ID: 11524031 [TBL] [Abstract][Full Text] [Related]
3. Statins in the treatment of acute ischemic stroke. Montecucco F; Quercioli A; Mirabelli-Badenier M; Viviani GL; Mach F Curr Pharm Biotechnol; 2012 Jan; 13(1):68-76. PubMed ID: 21470160 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotective properties of statins in cerebral ischemia and stroke. Vaughan CJ; Delanty N Stroke; 1999 Sep; 30(9):1969-73. PubMed ID: 10471452 [TBL] [Abstract][Full Text] [Related]
5. Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia. Miida T; Hirayama S; Nakamura Y J Atheroscler Thromb; 2004; 11(5):253-64. PubMed ID: 15557707 [TBL] [Abstract][Full Text] [Related]
6. Use of statins in CNS disorders. Cucchiara B; Kasner SE J Neurol Sci; 2001 Jun; 187(1-2):81-9. PubMed ID: 11440749 [TBL] [Abstract][Full Text] [Related]
7. The effects of statins on prevention of stroke and dementia: a review. Menezes AR; Lavie CJ; Milani RV; OʼKeefe J J Cardiopulm Rehabil Prev; 2012; 32(5):240-9. PubMed ID: 22785147 [TBL] [Abstract][Full Text] [Related]
8. The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration. Saeedi Saravi SS; Saeedi Saravi SS; Arefidoust A; Dehpour AR Metab Brain Dis; 2017 Aug; 32(4):949-965. PubMed ID: 28578514 [TBL] [Abstract][Full Text] [Related]
9. Effects of statins on ischemic stroke: neuroprotection and/or triggering of apoptotic damage? Duval D Stroke; 2000 Apr; 31(4):989-90. PubMed ID: 10754014 [No Abstract] [Full Text] [Related]
10. A Possible Role for HMG-CoA Reductase Inhibitors and Its Association with Pierzchlińska A; Droździk M; Białecka M Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830081 [TBL] [Abstract][Full Text] [Related]
11. The evolving role of statins in the management of atherosclerosis. Vaughan CJ; Gotto AM; Basson CT J Am Coll Cardiol; 2000 Jan; 35(1):1-10. PubMed ID: 10636252 [TBL] [Abstract][Full Text] [Related]
12. HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention. Hess DC; Demchuk AM; Brass LM; Yatsu FM Neurology; 2000 Feb; 54(4):790-6. PubMed ID: 10690964 [TBL] [Abstract][Full Text] [Related]
13. Vascular effects of statins in stroke. Delanty N; Vaughan CJ Stroke; 1997 Nov; 28(11):2315-20. PubMed ID: 9368582 [TBL] [Abstract][Full Text] [Related]
14. Statins in stroke: prevention, protection and recovery. Switzer JA; Hess DC Expert Rev Neurother; 2006 Feb; 6(2):195-202. PubMed ID: 16466299 [TBL] [Abstract][Full Text] [Related]
15. Advantages of lipid-lowering therapy in cerebral ischemia: role of HMG-CoA reductase inhibitors. Gil-Núñez AC; Villanueva JA Cerebrovasc Dis; 2001; 11 Suppl 1():85-95. PubMed ID: 11244205 [TBL] [Abstract][Full Text] [Related]
16. HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke. Moonis M; Fisher M Expert Rev Neurother; 2004 Mar; 4(2):241-7. PubMed ID: 15853565 [TBL] [Abstract][Full Text] [Related]
17. Prevention of stroke and dementia with statins: Effects beyond lipid lowering. Vaughan CJ Am J Cardiol; 2003 Feb; 91(4A):23B-29B. PubMed ID: 12615295 [TBL] [Abstract][Full Text] [Related]
18. [Pleiotrophic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors)]. Igel M; Sudhop T; von Bergmann K Arzneimittelforschung; 2003; 53(8):545-53. PubMed ID: 13677244 [TBL] [Abstract][Full Text] [Related]